10,621
Total Claims
$1.4M
Drug Cost
907
Beneficiaries
$1,524
Cost/Patient
Peer Comparison vs. 18,720 Cardiology providers
0%
Cost per patient vs peers
$1,524 vs $1,524 avg
-4%
Brand preference vs peers
13.1% vs 13.7% avg
Brand vs Generic
87% generic
Brand: 1,391 claims · $1.2M
Generic: 9,230 claims · $167K
Top Prescribed Drugs
| Drug (Generic) | Claims | Cost |
|---|---|---|
| Apixaban | 673 | $688K |
| Rivaroxaban | 255 | $268K |
| Sacubitril/Valsartan | 80 | $84K |
| Ticagrelor | 71 | $62K |
| Ivabradine Hcl | 35 | $42K |
| Empagliflozin | 42 | $35K |
| Metoprolol Succinate | 1,082 | $17K |
| Atorvastatin Calcium | 1,153 | $15K |
| Evolocumab | 15 | $14K |
| Ezetimibe | 248 | $9,045 |
| Dapagliflozin Propanediol | 12 | $8,559 |
| Flecainide Acetate | 148 | $7,469 |
| Isosorbide Mononitrate | 257 | $6,783 |
| Carvedilol | 583 | $6,406 |
| Diltiazem Hcl | 113 | $6,247 |
Prescribing Profile
58
Unique Drugs
$1.1M
Patient Profile
75
Avg Age
54%
Female
1.61
Avg Risk Score
Explore More
Data from CMS Medicare Part D Prescriber Public Use File, 2023. Risk scores are statistical indicators, not allegations of wrongdoing.Methodology · About · Dispute this data